Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Iridium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574487A details asymmetric hydrogenation for chiral dihydroisoflavones. Offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN1468852A reveals a breakthrough iridium-catalyzed method for asymmetric hydrogenation of aromatic heterocycles, offering high ee and scalable manufacturing for API intermediates.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN102924360A reveals efficient asymmetric hydrogenation for chiral indolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.